Network pharmacology-based identification and validation of novel vaccine candidates against brucellosis.
The development of a multi-epitope messenger RNA (mRNA) vaccine candidate targeting Brucella melitensis, the most pathogenic species responsible for human brucellosis is reported, establishing a promising platform for Brucella vaccine development warranting further evaluation in large animal models and human clinical t...